FMD Capital Management

Posts Tagged: biotechnology

3 ETF Charts Showing Red Flags

Written by David Fabian, March 22nd, 2017

I’m normally an optimistic, “glass-half-full” kind of guy.  I roll my eyes every time I see a headline decrying the next market crash or cataclysmic event that will cripple the global economy.  I’m quick to discern speculation from truths and prefer taking the opposite side of most mainstream assumptions.

It’s not that I see everything through rose colored glasses, but rather that I have found an unruffled approach to be a strong foundation for better decision making.  Navigating the markets with a calm and calculated strategy produces far superior returns than simply worrying about what dangers might lurk around every corner.  Read more

3 ETF Sectors Crushed By January Volatility

Written by David Fabian, February 02nd, 2016

January was a rough month in the stock market by almost any metric.  From an index standpoint, the U.S. concentrated SPDR S&P 500 ETF (SPY) dropped 5.07%, while the globally oriented iShares MSCI ACWI ETF (ACWI) fell 5.30%.  Both benchmarks would have been substantially worse if not for a late month rally that was spurred by oversold conditions alongside a sizeable rally in crude oil prices.

Many investors are now succumbing to the realization that volatility happens quickly and with little advance warning.  In fact, several high growth sectors experienced jaw-dropping moves in the month of January that are good examples of how quickly gains can evaporate in the midst of adverse conditions.

Read the complete article at NASDAQ.com

This Year’s Hottest Health Care ETFs

Written by David Fabian, July 23rd, 2014

As a sector, health care has a lot to offer in terms of fundamental and technical data that supports ongoing innovation and profitability. The aging baby boomer population combined with an increased focus on affordable health insurance is continuing to promote a focus on new drugs and medical devices aimed to increase quality of life. Read more

VIDEO: First Quarter 2014 Chart Review

Written by David Fabian, April 01st, 2014

In this video presentation we recap all of the market action in the first quarter of 2014 including some interesting correlations swirling beneath the surface.   Our analysis includes an in-depth review of charts, sectors, bonds, gold, and alternative investments using exchange-traded funds (ETFs).  Key areas include: small cap stocks, biotechnology, utilities, emerging markets, and the consumer discretionary sector. Recorded after the close of the market on 3/31/14.  A log of our previous videos are posted here.

To schedule a portfolio review or ask us a question, please click here.

VIDEO: March 2014 Chart Review

Written by David Fabian, March 12th, 2014

In this video presentation we review the latest charts of stocks, sectors, bonds, gold, and alternative investments using exchange-traded funds (ETFs).  Key areas include: small cap stocks, biotechnology, preferred stocks, Europe, and emerging market bonds. Recorded after the close of the market on 3/12/14.  Last month’s video is posted here.

)

To schedule a portfolio review or ask us a question, please click here.